DK1089963T3 - Hydroxamsyrederivater som inhibitorer af produktion af humant CD23 og af TBF-frigivelse - Google Patents

Hydroxamsyrederivater som inhibitorer af produktion af humant CD23 og af TBF-frigivelse

Info

Publication number: DK1089963T3
Authority: DK; Denmark
Prior art keywords: inhibitors; human; production; acid derivatives; hydroxamic acid
Prior art date: 1998-06-22

Application number

DK99928068T

Other languages

English (en)

Inventor

Andrew Faller

David T Macpherson

Peter H Milner

Jayshree Mistry

John Gerard Ward

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-22

Filing date

1999-06-22

Publication date

2004-10-18

1999-06-22 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2004-10-18 Application granted granted Critical

2004-10-18 Publication of DK1089963T3 publication Critical patent/DK1089963T3/da

Links

NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 title 1
102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 title 1
239000002253 acid Substances 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Transplantation (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyridine Compounds (AREA)
Cleaning Implements For Floors, Carpets, Furniture, Walls, And The Like (AREA)

DK99928068T 1998-06-22 1999-06-22 Hydroxamsyrederivater som inhibitorer af produktion af humant CD23 og af TBF-frigivelse DK1089963T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9813451.3A GB9813451D0 (en)	1998-06-22	1998-06-22	Novel compounds
EP99928068A EP1089963B1 (en)	1998-06-22	1999-06-22	Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release

Publications (1)

Publication Number	Publication Date
DK1089963T3 true DK1089963T3 (da)	2004-10-18

Family

ID=10834177

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99928068T DK1089963T3 (da)	1998-06-22	1999-06-22	Hydroxamsyrederivater som inhibitorer af produktion af humant CD23 og af TBF-frigivelse

Country Status (31)

Country	Link
US (1)	US6458779B1 (da)
EP (1)	EP1089963B1 (da)
JP (1)	JP2002518470A (da)
KR (1)	KR20010053076A (da)
CN (1)	CN1306508A (da)
AP (1)	AP2000002001A0 (da)
AR (1)	AR029303A1 (da)
AT (1)	ATE269296T1 (da)
AU (1)	AU744801B2 (da)
BG (1)	BG105154A (da)
BR (1)	BR9911423A (da)
CA (1)	CA2335513A1 (da)
DE (1)	DE69918113T2 (da)
DK (1)	DK1089963T3 (da)
EA (1)	EA200100065A1 (da)
ES (1)	ES2222711T3 (da)
GB (1)	GB9813451D0 (da)
HU (1)	HUP0102776A3 (da)
ID (1)	ID27413A (da)
IL (1)	IL139738A (da)
MY (1)	MY121785A (da)
NO (1)	NO20006349D0 (da)
NZ (1)	NZ508229A (da)
OA (1)	OA11639A (da)
PL (1)	PL345038A1 (da)
PT (1)	PT1089963E (da)
SI (1)	SI1089963T1 (da)
SK (1)	SK19562000A3 (da)
TR (1)	TR200003877T2 (da)
WO (1)	WO1999067201A1 (da)
ZA (1)	ZA200007254B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020082200A1 (en) *	1994-07-13	2002-06-27	Smithkline Beecham P.1.C.	Use of inhibitors of human S-CD23
EP1169031A1 (en) *	1999-04-09	2002-01-09	British Biotech Pharmaceuticals Limited	Antimicrobial agents
GB9925470D0 (en) *	1999-10-27	1999-12-29	Smithkline Beecham Plc	Novel compounds
GB9929527D0 (en) *	1999-12-14	2000-02-09	Smithkline Beecham Plc	Novel compounds
EP1265855A1 (en) *	2000-02-24	2002-12-18	Smithkline Beecham Plc	Novel cd23 inhibitors
WO2004076386A2 (en)	2003-02-25	2004-09-10	Topotarget Uk Limited	Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9223904D0 (en)	1992-11-13	1993-01-06	British Bio Technology	Inhibition of cytokine production
GB9414157D0 (en)	1994-07-13	1994-08-31	Smithkline Beecham Plc	Medical use
GB9507799D0 (en) *	1995-04-18	1995-05-31	British Biotech Pharm	Metalloproteinase inhibitors
US5691381A (en)	1995-04-18	1997-11-25	The Dupont Merck Pharmaceutical Company	Hydroxamic and carbocyclic acids as metalloprotease inhibitors
GB9513331D0 (en)	1995-06-30	1995-09-06	British Biotech Pharm	Matrix metalloproteinase inhibitors
AU7335496A (en)	1995-10-23	1997-05-15	Sankyo Company Limited	Hyroxamic acid derivatives
GB9609794D0 (en) *	1996-05-10	1996-07-17	Smithkline Beecham Plc	Novel compounds
JP2001518090A (ja) *	1997-03-28	2001-10-09	ゼネカリミテッド	腫瘍壊死因子の阻害に有用な複素環により置換したヒドロキサム酸

1998
- 1998-06-22 GB GBGB9813451.3A patent/GB9813451D0/en not_active Ceased
1999
- 1999-06-22 ES ES99928068T patent/ES2222711T3/es not_active Expired - Lifetime
- 1999-06-22 AP APAP/P/2000/002001A patent/AP2000002001A0/en unknown
- 1999-06-22 KR KR1020007014549A patent/KR20010053076A/ko not_active Ceased
- 1999-06-22 AU AU45195/99A patent/AU744801B2/en not_active Ceased
- 1999-06-22 MY MYPI99002571A patent/MY121785A/en unknown
- 1999-06-22 TR TR2000/03877T patent/TR200003877T2/xx unknown
- 1999-06-22 OA OA1200000359A patent/OA11639A/en unknown
- 1999-06-22 BR BR9911423-2A patent/BR9911423A/pt not_active IP Right Cessation
- 1999-06-22 CA CA002335513A patent/CA2335513A1/en not_active Abandoned
- 1999-06-22 SI SI9930648T patent/SI1089963T1/xx unknown
- 1999-06-22 PL PL99345038A patent/PL345038A1/xx not_active Application Discontinuation
- 1999-06-22 JP JP2000555856A patent/JP2002518470A/ja active Pending
- 1999-06-22 HU HU0102776A patent/HUP0102776A3/hu unknown
- 1999-06-22 DE DE69918113T patent/DE69918113T2/de not_active Expired - Fee Related
- 1999-06-22 EP EP99928068A patent/EP1089963B1/en not_active Expired - Lifetime
- 1999-06-22 US US09/701,946 patent/US6458779B1/en not_active Expired - Fee Related
- 1999-06-22 CN CN99807653A patent/CN1306508A/zh active Pending
- 1999-06-22 SK SK1956-2000A patent/SK19562000A3/sk unknown
- 1999-06-22 AT AT99928068T patent/ATE269296T1/de not_active IP Right Cessation
- 1999-06-22 EA EA200100065A patent/EA200100065A1/ru unknown
- 1999-06-22 IL IL13973899A patent/IL139738A/en not_active IP Right Cessation
- 1999-06-22 PT PT99928068T patent/PT1089963E/pt unknown
- 1999-06-22 AR ARP990102994A patent/AR029303A1/es unknown
- 1999-06-22 ID IDW20002683A patent/ID27413A/id unknown
- 1999-06-22 WO PCT/GB1999/001954 patent/WO1999067201A1/en not_active Ceased
- 1999-06-22 DK DK99928068T patent/DK1089963T3/da active
- 1999-06-22 NZ NZ508229A patent/NZ508229A/en unknown
2000
- 2000-12-07 ZA ZA200007254A patent/ZA200007254B/en unknown
- 2000-12-13 NO NO20006349A patent/NO20006349D0/no not_active Application Discontinuation
2001
- 2001-01-15 BG BG105154A patent/BG105154A/bg unknown

Also Published As

Publication number	Publication date
AR029303A1 (es)	2003-06-25
SI1089963T1 (en)	2004-12-31
IL139738A (en)	2005-12-18
JP2002518470A (ja)	2002-06-25
ATE269296T1 (de)	2004-07-15
CA2335513A1 (en)	1999-12-29
EP1089963A1 (en)	2001-04-11
ES2222711T3 (es)	2005-02-01
ZA200007254B (en)	2002-02-07
BR9911423A (pt)	2001-03-13
IL139738A0 (en)	2002-02-10
WO1999067201A1 (en)	1999-12-29
DE69918113D1 (de)	2004-07-22
GB9813451D0 (en)	1998-08-19
HUP0102776A3 (en)	2002-11-28
AP2000002001A0 (en)	2000-12-31
TR200003877T2 (tr)	2001-06-21
EP1089963B1 (en)	2004-06-16
OA11639A (en)	2004-11-27
AU4519599A (en)	2000-01-10
CN1306508A (zh)	2001-08-01
SK19562000A3 (sk)	2001-08-06
NZ508229A (en)	2003-12-19
MY121785A (en)	2006-02-28
HK1025894A1 (en)	2000-12-01
DE69918113T2 (de)	2005-07-07
NO20006349L (no)	2000-12-13
KR20010053076A (ko)	2001-06-25
PT1089963E (pt)	2004-10-29
EA200100065A1 (ru)	2001-06-25
HUP0102776A2 (hu)	2001-12-28
ID27413A (id)	2001-04-05
AU744801B2 (en)	2002-03-07
PL345038A1 (en)	2001-11-19
US6458779B1 (en)	2002-10-01
NO20006349D0 (no)	2000-12-13
BG105154A (bg)	2001-08-31

Publication	Publication Date	Title
DK0934301T3 (da)	2001-10-08	Aminothiophencarboxylsyreamider og anvendelse deraf som phosphodiesteraseinhibitorer
DK1084102T3 (da)	2004-02-02	Nye 3-arylpropionsyrederivater og analoge
HUP0401233A3 (en)	2007-05-29	Aromatic hydroxamic acid derivatives useful as hdac inhibitors
NO996491L (no)	1999-12-29	4-brom- eller 4-iod-fenylaminobenzhydroksamsyre-derivater og deres anvendelse som MEK-inhibitorer
IS7792A (is)	2005-04-11	Hýdantóínafleiður og notkun þeirra sem TACE hemla
IS6899A (is)	2003-07-30	Samsetning og andveiruvirkni tengdra azaindóloxóediksýru píperazín afleiða
NO20010686D0 (no)	2001-02-09	Hydroksypipecolathydroksaminsyrederivater som MMP inhibitorer
IS2919B (is)	2015-01-15	Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna
DE60035631D1 (de)	2007-09-06	Inhibitoren der Interleukin-4 Produktion
NO20020596D0 (no)	2002-02-06	Arylsulfonamidsubstituerte hydroksaminsyrederivater
AU2328300A (en)	2000-08-07	Life span lengthening device for efficient use of battery
DK1224164T3 (da)	2005-03-29	Hydroxaminsyrederivat som inhibitor for produktion af oplöselig human CD23
PL356092A1 (en)	2004-06-14	Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
NO20006349D0 (no)	2000-12-13	Hydroksamsyrederivater som inhibitorer for produksjon av humant CD23 og av TNF-frigjöring
DK1228026T3 (da)	2004-04-05	15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
NO20014770D0 (no)	2001-10-01	Assosiasjon av NO-syntase inhibitor(er) og metabolske antioksidanter
AU2002246926A1 (en)	2002-08-06	12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
IL139731A0 (en)	2002-02-10	N-acetyl 3-chloropocainamide, acid addition salts thereof, and methods of use
DK1187812T3 (da)	2005-12-12	Substituerede phenylcyclohexancarboxylsyreamider og deres anvendelse som adenosinoptagelses-inhibitorer
GB0230240D0 (en)	2003-02-05	Removal of an acid
DK1227809T3 (da)	2005-05-17	Heteroatom-afbrudte analoger af 15-hydroxyeicosatetraensyre og fremgangsmåder til anvendelse
AR028007A1 (es)	2003-04-23	Procedimiento para preparar eteres de oxima
AU1872001A (en)	2001-06-25	Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release
NO20001447D0 (no)	2000-03-20	Modifisert polyasparginsyre og fremgangsmåte for produksjon og bruk derav
PL354071A1 (en)	2003-12-01	New derivatives of 4-imine-1,4-dihydro-cinnoline-3-carboxyl acid and method of receiving new derivatives of 4-imine-1,4-dihydro-cinnoline-3-carboxyl acid